Singapore’s UltraGreen.ai posts 24% revenue rise in FY2025
- ByStartupStory | February 26, 2026
UltraGreen.ai, a Singapore-based surgical imaging firm, reported a 24% revenue rise for the finance year 2025 (FY2025) to US$142.4 million, driven by a 13% increase in vial volumes and higher prices, especially in the United States and Europe.
The company’s gross margin stayed at 85%, with operating profit rising to US$84.2 million despite higher expenses from commercial scale-up in Asia, regulatory work, and IPO-related costs.
Underlying net profit after tax before exceptional items rose 14% to US$63.8 million.
The firm ended FY2025 with no debt and a net cash position of US$176.1 million.
The company forecast FY2026 revenue of US$170 million to US$190 million, a 19% to 33% rise, respectively.
The FY2025 results include discontinued operations from the UltraLinq business, sold in August 2025.
🔗 Source: UltraGreen.ai
Follow Startup Story
Related Posts
